| |
| |
|
| Insider
Information: |
Orbimed Capital Gp Vi Llc |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
17 |
|
| Direct
Shares |
5,826,224 |
|
|
Indirect Shares
|
46,949,846 |
|
|
| Direct
Value |
$193,255,850 |
|
|
|
Indirect Value
|
$504,861,587 |
|
|
| Total
Shares |
52,776,070 |
|
|
| Total
Value |
$698,117,437 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
16
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -513.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synlogic Inc |
SYBX |
Director |
|
0 |
2021-04-20 |
3,696,662 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
10% Owner |
2018-01-12 |
0 |
2018-02-08 |
3,447,840 |
Premium* |
|
|
Adicet Bio, Inc |
ACET |
Director, 10% Owner |
2018-01-30 |
0 |
2018-01-30 |
4,830,387 |
Premium* |
|
|
Constellation Pharmaceuticals Inc |
CNST |
10% Owner |
2018-07-23 |
0 |
2018-07-23 |
417,921 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Director, 10% Owner |
2019-01-18 |
0 |
2020-12-28 |
3,070,955 |
Premium* |
|
|
Turning Point Therapeutics, Inc. |
TPTX |
Director |
2019-04-22 |
0 |
2019-04-22 |
2,027,550 |
Premium* |
|
|
Nextcure, Inc. |
NXTC |
Director, 10% Owner |
2019-05-13 |
0 |
2019-05-13 |
2,711,013 |
Premium* |
|
|
Prevail Therapeutics Inc. |
PRVL |
Director, 10% Owner |
|
0 |
2021-01-22 |
0 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
10% Owner |
2019-09-17 |
0 |
2022-09-12 |
5,599,842 |
Premium* |
|
|
Cti Biopharma Corporation |
CTIC |
10% Owner |
|
0 |
2021-01-07 |
7,520,600 |
Premium* |
|
|
Oric Pharmaceuticals, Inc. |
ORIC |
Director |
2020-04-24 |
0 |
2021-03-30 |
2,212,571 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
Director, 10% Owner |
|
0 |
2020-09-24 |
206,912 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
10% Owner |
2020-09-25 |
0 |
2020-09-29 |
4,163,347 |
Premium* |
|
|
Silverback Therapeutics, Inc. |
SBTX |
Director, 10% Owner |
|
0 |
2020-12-03 |
538,646 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
Director, 10% Owner |
2021-02-05 |
5,826,224 |
|
0 |
Premium* |
|
|
Neuropace Inc |
NPCE |
10% Owner |
2021-04-21 |
0 |
2024-05-03 |
3,406,335 |
Premium* |
|
|
Turnstone Biologics Corp. |
TSBX |
Director, 10% Owner |
2023-07-20 |
0 |
2023-07-20 |
3,099,265 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2021-03-01 |
4 |
S |
$83.19 |
$101,491,800 |
I/I |
(1,220,000) |
6,186,307 |
0 |
- |
|
| PRVL |
Prevail Therapeutics Inc. |
Director |
– • • |
2019-06-24 |
4 |
B |
$17.00 |
$14,999,984 |
I/I |
882,352 |
13,822,463 |
2.25 |
- |
|
| CALC |
Calcimedica Ord Shs |
10% Owner |
– – • |
2020-09-25 |
4 |
B |
$16.00 |
$9,000,000 |
I/I |
562,500 |
562,500 |
1.5 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Director |
– • • |
2020-12-28 |
4 |
S |
$14.25 |
$8,550,000 |
I/I |
(600,000) |
3,070,955 |
0 |
% |
|
| ACET |
Adicet Bio, Inc |
Director |
– • • |
2018-01-30 |
4 |
B |
$15.00 |
$7,999,995 |
I/I |
533,333 |
4,830,387 |
2.25 |
- |
|
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2022-08-08 |
4 |
S |
$38.33 |
$7,857,650 |
I/I |
(205,000) |
5,823,307 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
10% Owner |
– – • |
2021-01-07 |
4 |
S |
$3.50 |
$7,000,000 |
I/I |
(2,000,000) |
7,520,600 |
0 |
% |
|
| SYBX |
Synlogic Inc |
Director |
– • – |
2018-01-26 |
4 |
A |
$9.75 |
$6,971,250 |
I/I |
715,000 |
2,029,996 |
0 |
- |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2024-04-11 |
4 |
S |
$14.49 |
$6,692,917 |
I/I |
(461,899) |
3,542,068 |
0 |
% |
|
| TPTX |
Turning Point Therapeutic... |
Director |
– • – |
2019-04-22 |
4 |
B |
$18.00 |
$6,480,000 |
I/I |
360,000 |
2,027,550 |
2.1 |
- |
|
| NXTC |
Nextcure, Inc. |
Director |
– • • |
2019-05-13 |
4 |
B |
$15.00 |
$5,250,000 |
I/I |
350,000 |
2,711,013 |
2.25 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
– – • |
2018-01-31 |
4 |
B |
$15.00 |
$5,091,000 |
I/I |
339,400 |
3,362,160 |
1.5 |
- |
|
| SYBX |
Synlogic Inc |
Director |
– • – |
2021-04-20 |
4 |
A |
$3.00 |
$4,999,998 |
I/I |
1,666,666 |
3,696,662 |
0 |
- |
|
| TSBX |
Turnstone Biologics Corp. |
Director |
– • • |
2023-07-20 |
4 |
B |
$12.00 |
$4,999,992 |
I/I |
416,666 |
3,099,265 |
2.25 |
- |
|
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2019-09-17 |
4 |
B |
$18.00 |
$4,950,000 |
I/I |
275,000 |
7,406,307 |
1.5 |
- |
|
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2022-09-12 |
4 |
S |
$31.96 |
$4,919,148 |
I/I |
(153,897) |
5,599,842 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • • |
2020-04-24 |
4 |
B |
$16.00 |
$4,500,000 |
I/I |
281,250 |
281,250 |
2.25 |
- |
|
| NPCE |
Neuropace Inc |
10% Owner |
– – • |
2021-04-21 |
4 |
B |
$17.00 |
$3,995,000 |
I/I |
235,000 |
235,000 |
1.5 |
- |
|
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2021-06-08 |
4 |
AS |
$85.37 |
$3,639,579 |
I/I |
(42,633) |
6,143,303 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
10% Owner |
– – • |
2018-07-23 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
417,921 |
1.5 |
- |
|
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2021-06-24 |
4 |
AS |
$85.22 |
$2,914,524 |
I/I |
(34,200) |
6,073,102 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-12 |
4 |
AS |
$30.29 |
$2,741,881 |
I/I |
(90,521) |
2,616,645 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2021-06-10 |
4 |
AS |
$85.09 |
$2,625,197 |
I/I |
(30,852) |
6,107,402 |
0 |
- |
|
| SWTX |
Springworks Therapeutics,... |
10% Owner |
– – • |
2022-08-09 |
4 |
S |
$37.47 |
$2,606,713 |
I/I |
(69,568) |
5,753,739 |
0 |
- |
|
| ORIC |
Oric Pharmaceuticals, Inc... |
Director |
– • – |
2021-03-15 |
4 |
AS |
$29.14 |
$2,599,579 |
I/I |
(89,210) |
2,527,435 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
